Oncology (all articles)
Randomized Trial: FLAURA Trial – Treatments for EGFR-Mutated Advanced Non–small-cell Lung Cancer Compared
26 Nov, 2019 | 08:16h | UTCOverall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC – New England Journal of Medicine (free for a limited period)
Commentary: FLAURA Trial: First-Line Osimertinib Improves Overall Survival in EGFR-Mutated Advanced Lung Cancer – The ASCO Post (free)
Perspective: A Cancer Care Approach Tailored to The Elderly May Have Better Results
26 Nov, 2019 | 08:09h | UTCA Cancer Care Approach Tailored to The Elderly May Have Better Results – NPR (free)
Related: Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology – Journal of Clinical Oncology (free) AND International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer – Journal of Clinical Oncology (free PDF) AND What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper – Journal of Clinical Oncology (free) AND Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts – Journal of the National Comprehensive Cancer Network (free)
Study: Cancer Patients Have an on Average 2–6 Times Higher CVD Mortality Risk than the General Population
26 Nov, 2019 | 08:00h | UTCA population-based study of cardiovascular disease mortality risk in US cancer patients – European Heart Journal (free for a limited period)
Editorial: From trends to transformation: where cardio-oncology is to make a difference – European Heart Journal (free)
Commentaries: Cancer patients are at higher risk of dying from heart disease and stroke – European Society of Cardiology (free) AND Cancer survivors ‘have higher heart risk’ – BBC (free)
Related Commentary on Twitter
Patients w/ #cancer have a 2-6 times higher mortality from cardiovascular disease than the general population https://t.co/LrfaYstH8F @escardio @ESC_Journals
report by @NicholasZaorsky, Kathleen Sturgeon @PSHResearch and collaborators; editorial by @mayocvonc pic.twitter.com/8TqiJyQnZl— Eric Topol (@EricTopol) November 25, 2019
[Abstract Only] Randomized Trial: Similar Survival Outcomes After Laparoscopy-assisted Distal Gastrectomy vs. Open Distal Gastrectomy for Clinical Stage I Gastric Cancer
26 Nov, 2019 | 07:59h | UTCSurvival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Related Commentary on Twitter
New online – survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB #gastriccancer (JCOG0912 trial) – https://t.co/SMUsDqKMS7 #SoMe4Surg #stcsm pic.twitter.com/WHyrgZSTUe
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) November 20, 2019
Review: Immune Checkpoint Inhibitor-associated Gastrointestinal and Hepatic Adverse Events and Their Management
26 Nov, 2019 | 07:34h | UTCRelated: Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor – Portuguese Journal of Gastroenterology (free) AND Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer
24 Nov, 2019 | 20:43h | UTC
Consensus Recommendations: Management of Adults and Children Undergoing CAR T-Cell Therapy
24 Nov, 2019 | 20:42h | UTC
Meta-Analysis: Early vs. Delayed Surgery After Short-course Radiotherapy for Rectal Cancer
24 Nov, 2019 | 20:41h | UTC
Current Management of Barrett Esophagus and Esophageal Adenocarcinoma
18 Nov, 2019 | 00:24h | UTCRelated: Review: Barrett Esophagus (free guidelines and review on the subject)
Meta-Analysis: Outcomes at Follow-up of Negative Colonoscopy in Average Risk Population
15 Nov, 2019 | 10:25h | UTCRelated Guidelines: ACP Guideline: Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults (free) AND BMJ Guideline: Colorectal Cancer Screening with Fecal Immunochemical Testing, Sigmoidoscopy or Colonoscopy (new guideline suggesting a more selective approach to screening) AND Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society (recent guideline with recommendation to start screening at 45 years, with links to guidelines from other organizations)
“Our findings suggest that 10 year intervals for colonoscopy screening after a negative colonoscopy, as currently recommended, may be adequate”
[Abstract Only] Randomized Trial: Secondary Surgical Cytoreduction Not Beneficial for Recurrent Ovarian Cancer
14 Nov, 2019 | 10:34h | UTCSecondary Surgical Cytoreduction for Recurrent Ovarian Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Secondary surgery does not improve overall survival for recurrent ovarian cancer patients – University of Texas M. D. Anderson Cancer Center (free) AND Second surgery for many ovarian cancers found ineffective – Reuters (free)
Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation
14 Nov, 2019 | 10:32h | UTC
ACR Consensus Guideline: O-RADS Risk Stratification and Management System for Ovarian-Adnexal Reporting
12 Nov, 2019 | 11:25h | UTC
Onco-Nephrology: Cancer, Chemotherapy and Kidney
12 Nov, 2019 | 11:15h | UTCOnco-Nephrology: Cancer, chemotherapy and kidney – Nephrología (free)
Related: Onco-Nephrology: Core Curriculum – American Journal of Kidney Diseases (free) AND Onco-nephrology: an appraisal of the cancer and chronic kidney disease links – Nephrology Dialysis Transplantation (free) AND Opening an onconephrology clinic: recommendations and basic requirements – Nephrology Dialysis Transplantation (free) AND Onco-nephrology: current concepts and future perspectives – Japanese Journal of Clinical Oncology (free)
Guideline: Diagnosis, Therapy and Follow-up of Vaginal Cancer
12 Nov, 2019 | 10:53h | UTC
#ACR19 – [Not Published Yet] Cohort Study: Half of People with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors for Cancer Experience Flare, but Most Able to Continue Treatment
12 Nov, 2019 | 10:45h | UTCAbstract: Risk of Immunotherapy Related Toxicity in Patients with Rheumatoid Arthritis (free)
#ACR19 – Just Presented at the 2019 American College of Rheumatology Annual Meeting
[Abstract Only] Randomized Trial: Treatments for Relapsed or Refractory FLT3-mutated Acute Myeloid Leukemia Compared
10 Nov, 2019 | 12:57h | UTCGilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: ADMIRAL: Gilteritinib vs Chemotherapy in Relapsed or Refractory FLT3-Mutated AML – The ASCO Post (free)
NCCN Guidelines: Gestational Trophoblastic Neoplasia
10 Nov, 2019 | 12:51h | UTC
NCCN Guidelines Insights: Kidney Cancer
10 Nov, 2019 | 12:49h | UTC
Viewpoint: Neuroendocrine Tumors—Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence
8 Nov, 2019 | 06:48h | UTCNeuroendocrine Tumors—Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence – JAMA Oncology (free for a limited period)
Review: Dermatologic Conditions in Women Receiving Systemic Cancer Therapy
8 Nov, 2019 | 06:46h | UTC
ACP Guideline: Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults
5 Nov, 2019 | 10:43h | UTCNews Release: ACP issues guidance for colorectal cancer screening – American College of Physicians (free)
Summaries for Patients: Colorectal Cancer Screening in Average-Risk Adults (free)
Commentaries: ACP issues new guidance on colorectal cancer screening – ACP Internist (free) AND Medical groups differ on when to start colon and rectal cancer screening. Here’s why – CNN (free)
Related: BMJ Guideline: Colorectal Cancer Screening with Fecal Immunochemical Testing, Sigmoidoscopy or Colonoscopy (new guideline suggesting a more selective approach to screening) AND Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society (recent guideline with recommendation to start screening at 45 years, with links to guidelines from other organizations)
Cohort Study: Incidence of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
4 Nov, 2019 | 00:24h | UTCThe Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors – Clinical Journal of the American Society of Nephrology (free for a limited period)
News Release: Study Examines Kidney Injury in Patients Taking Immunotherapy Cancer Medications – American Society of Nephrology (free)
Related: Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)
Related Commentary on Twitter
https://twitter.com/CJASN/status/1190342954830966785
Perspective: The Oncology Care Model—Why It Works and Why It Could Work Better: Accounting for Novel Therapies in Value-Based Payment
3 Nov, 2019 | 19:56h | UTCThe Oncology Care Model—Why It Works and Why It Could Work Better: Accounting for Novel Therapies in Value-Based Payment – JAMA Oncology (free for a limited period)
Randomized Trial: Levofloxacin Prophylaxis Reduces Early Deaths in Patients with Newly Diagnosed Myeloma
30 Oct, 2019 | 08:17h | UTCCommentaries: Reducing infection-related morbidity and mortality in patients with myeloma – The Lancet Oncology (free) AND Abx Prophylaxis Cuts Early Death in Newly Diagnosed Myeloma – MedPage Today (free)